Plasmon resonant liposomes for controlled drug delivery

Shellie S. Knights-Mitchell; Marek Romanowski

doi:10.1117/12.2080485

12 March 2015 Plasmon resonant liposomes for controlled drug delivery

Shellie S. Knights-Mitchell, Marek Romanowski

Proceedings Volume 9338, Colloidal Nanoparticles for Biomedical Applications X; 93381D (2015) https://doi.org/10.1117/12.2080485
Event: SPIE BiOS, 2015, San Francisco, California, United States

Abstract

Nanotechnology use in drug delivery promotes a reduction in systemic toxicity, improved pharmacokinetics, and better drug bioavailability. Liposomes continue to be extensively researched as drug delivery systems (DDS) with formulations such as Doxil^® and Ambisome^® approved by FDA and successfully marketed in the United States. However, the limited ability to precisely control release of active ingredients from these vesicles continues to challenge the broad implementation of this technology. Moreover, the full potential of the carrier to sequester drugs until it can reach its intended target has yet to be realized. Here, we describe a liposomal DDS that releases therapeutic doses of an anticancer drug in response to external stimulus. Earlier, we introduced degradable plasmon resonant liposomes. These constructs, obtained by reducing gold on the liposome surface, facilitate spatial and temporal release of drugs upon laser light illumination that ultimately induces an increase in temperature. In this work, plasmon resonant liposomes have been developed to stably encapsulate and retain doxorubicin at physiological conditions represented by isotonic saline at 37^o C and pH 7.4. Subsequently, they are stimulated to release contents either by a 5^o C increase in temperature or by laser illumination (760 nm and 88 mW/cm² power density). Successful development of degradable plasmon resonant liposomes responsive to near-infrared light or moderate hyperthermia can provide a new delivery method for multiple lipophilic and hydrophilic drugs with pharmacokinetic profiles that limit clinical utility.

Citation Download Citation

Shellie S. Knights-Mitchell and Marek Romanowski "Plasmon resonant liposomes for controlled drug delivery", Proc. SPIE 9338, Colloidal Nanoparticles for Biomedical Applications X, 93381D (12 March 2015); https://doi.org/10.1117/12.2080485

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
8 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Plasmons

Gold

Luminescence

Semiconductor lasers

Absorbance

Nanoparticles

Nanotechnology

Show All Keywords

Keywords/Phrases

Search In:

Publication Years